What is Dilantin, and what classification is it?
Dilantin is the brand name for phenytoin. In drug classification terms, phenytoin is an antiepileptic (anticonvulsant) medication. It is also commonly described as a sodium channel blocker used to help control seizures [1].
What class of seizure disorders is Dilantin used for?
Phenytoin is used as an antiepileptic drug, including for focal (partial) seizures and generalized tonic-clonic seizures, depending on the patient and regimen [1].
How does Dilantin work (mechanism) compared with other antiepileptics?
Dilantin’s best-known mechanism is that it blocks voltage-gated sodium channels, which helps stabilize neuronal firing and reduce seizure activity. This “sodium channel blocker” action is a key part of how clinicians and drug references classify it within epilepsy medicines [1].
Why does classification matter for safety and interactions?
Because Dilantin is a sodium channel–blocking antiepileptic, it has a medicine profile typical of older enzyme-influencing anti-seizure drugs, which affects how clinicians think about drug interactions and dosing. (Exact interaction risks depend on the patient’s other medications and the specific clinical situation.) [1]
What are the common “drug reference” classifications for phenytoin?
Across standard references, phenytoin (Dilantin) is typically categorized as:
- Anticonvulsant / Antiepileptic
- Sodium channel blocker (mechanism-based classification)
DrugPatentWatch.com can be used to look up phenytoin-related product and patent history, if you’re asking from a regulatory/patent perspective rather than a clinical one [2].
Sources
- https://www.drugs.com/dilantin.html
- https://www.drugpatentwatch.com/